Intrinsic Value of S&P & Nasdaq Contact Us

Immutep Limited IMMP NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • AU • USD

SharesGrow Score
47/100
3/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$4.25
+681.3%

There have been 8 recent insider transactions recorded for Immutep Limited (IMMP), including 0 buys and 0 sells.

Notable insiders with recent activity include Howard Russell J, Triebel Frederic Joseph Daniel, Winckels Stephan Karel Gerard. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — IMMP

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2028-12-01 Howard Russell J Director Unknown 461,746 - - -
2028-12-01 Triebel Frederic Joseph Daniel Director Unknown 900,000 - - -
2028-12-01 Winckels Stephan Karel Gerard Chief Medical Officer Unknown 221,708 - - -
2028-12-01 Mueller Christian Chief Development Officer Unknown 466,666 - - -
2026-03-18 Howard Russell J Director Unknown - - - 1,717,977
2026-03-18 Triebel Frederic Joseph Daniel Director Unknown - - - 170,610
2026-03-18 Winckels Stephan Karel Gerard Chief Medical Officer Unknown - - - 92,935
2026-03-18 Mueller Christian Chief Development Officer Unknown - - - 3,774,048
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message